The 3,600 sqft facility will help develop the MIMIX sustained-release intradermal microneedle patch, which is planned for proof-of-concept trials for COVID-19 in 2022
Hear from NASA, AstraZeneca and STERIS at the Cleanroom Technology Conference 2024. This year's agenda has launched and delegates will have the opportunity to converse with...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.